BIB_431
Cannabis / cannabinoids (CBD/THC) & cancer immunotherapy — evidence-anchored, ANTI-ALARMIST literacy. Fills a real gap: cannabinoids are discussed in TASK12 §10 / TASK11 but with NO graded BIB anchor, and the decision-relevant cannabinoid–ICI outcome question was uncaptured. The honest synthesis CORRECTS a likely over-statement in both directions: (a) CBD/cannabis has NO anti-melanoma benefit (wellness/longevity claim — false); (b) the early "cannabis ruins immunotherapy" signal is from small CONFOUNDED cohorts and is NOT supported by the best current synthesis — so it must not be framed ala…
- Evidence grade
- C
- Tier
- 2 (recent systematic review, 40 studies incl. 9 RCTs; the ICI-outcome interactio
- Cited by tasks
- 11, 12, 22a
- Identifiers
- PMC12629512
↗ Follow the original source for full context
Full extracted findings & patient-implication analysis: bibliography/BIB_431/findings.md (research corpus). This page is a short context summary — not individualised medical advice.